Press releases Image EN FR Corporate / 08.02.2024 IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence Read more IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
Press releases Image FR EN Corporate / 05.02.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 01.02.2024 IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care. Read more IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care.
Press releases Image FR EN Corporate / 31.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR RadioPharma Solutions / 23.01.2024 iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70 Read more iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
Press releases Image FR EN Corporate / 09.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Industrial Solutions / 22.12.2022 IBA signs contract to install a fully integrated X-ray irradiation solution in France Read more IBA signs contract to install a fully integrated X-ray irradiation solution in France
Press releases Image EN FR Proton Therapy / 08.12.2022 IBA Wins 10 Proton Therapy System Contract in Spain Read more IBA Wins 10 Proton Therapy System Contract in Spain
Press releases Image FR EN Corporate / 17.11.2022 IBA Business Update – Third Quarter 2022 Read more IBA Business Update – Third Quarter 2022
Press releases Image EN FR Corporate / 16.11.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image FR EN Dosimetry / 24.10.2022 IBA Dosimetry expands its myQA® iON technology into Radiation Therapy Read more IBA Dosimetry expands its myQA® iON technology into Radiation Therapy
Press releases Image EN FR Dosimetry / 20.10.2022 IBA announces compatibility of its dosimetry solutions with Halcyon® and Ethos™ radiotherapy and adaptive therapy solutions Read more IBA announces compatibility of its dosimetry solutions with Halcyon® and Ethos™ radiotherapy and adaptive therapy solutions
Press releases Image EN FR RadioPharma Solutions / 13.10.2022 IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, Ghana Read more IBA expands its activities in Sub-Saharan Africa and signs contract with Sweden Ghana Medical Centre for an IntegraLab® PLUS in Accra, Ghana
Press releases Image EN FR Corporate / 12.10.2022 IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region Read more IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region
Press releases Image EN FR Industrial Solutions / 06.10.2022 IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan Read more IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan
Press releases Image FR EN RadioPharma Solutions / 04.10.2022 ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia Read more ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia
Press releases Image EN FR RadioPharma Solutions / 22.09.2022 IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225 Read more IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
Press releases Image EN FR Industrial Solutions / 20.09.2022 NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes Read more NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes
Reports Image EN FR Corporate / 01.09.2022 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022 Read more UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022
Press releases Image EN FR Proton Therapy / 01.09.2022 The PROTECT-trial consortium enrolls first patient into proton therapy study Read more The PROTECT-trial consortium enrolls first patient into proton therapy study
